Table 2 Cardiometabolic variables at baseline, at end of LD and at end of HD
From: Dairy consumption and cardiometabolic health: outcomes of a 12-month crossover trial
Variable | Baseline | End HD | End LD | Change HD-LD | P-value* |
|---|---|---|---|---|---|
n | 36 | 36 | 36 | 36 | Â |
RMR (MJ/d) | 6.7 ± 0.3 | 6.9 ± 0.3 | 6.9 ± 0.3 | 0.06 ± 0.3 | 0.86 |
Energy expenditure (MJ/d) | 16.1 ± 0.7 | 16.1 ± 0.7 | 15.9 ± 0.7 | 0.3 ± 0.4 | 0.51 |
Body weight (kg) | 88.6 ± 2.9 | 90.8 ± 3.0 | 90.3 ± 3.0 | 0.5 ± 0.5 | 0.29 |
BMI (kg/m2) | 31.5 ± 0.9 | 32.2 ± 1.0 | 32.0 ± 0.9 | 0.2 ± 0.2 | 0.20 |
Waist circumference (cm) | 98.2 ± 2.4 | 98.9 ± 2.4 | 98.3 ± 2.5 | 0.6 ± 0.6 | 0.33 |
Hip circumference (cm) | 114.3 ± 2.0 | 115.8 ± 2.1 | 115.4 ± 2.1 | 0.5 ± 0.3 | 0.18 |
Body fat (%) | 43.0 ± 1.5 | 43.6 ± 1.5 | 43.5 ± 1.5 | 0.1 ± 0.3 | 0.67 |
Fat mass (kg) | 36.6 ± 1.9 | 38.0 ± 2.0 | 37.7 ± 2.0 | 0.3 ± 0.4 | 0.46 |
Lean mass (kg) | 48.0 ± 1.9 | 48.5 ± 1.9 | 48.3 ± 1.9 | 0.1 ± 0.3 | 0.60 |
Abdominal fat (kg) | 2.6 ± 0.2 | 2.7 ± 0.2 | 2.7 ± 0.2 | -0.01 ± 0.03 | 0.71 |
Bone mineral density (g/cm2) | 1.3 ± 0.02 | 1.3 ± 0.02 | 1.2 ± 0.02 | 0.002 ± 0.004 | 0.65 |
SBP (mm Hg) | 125.9 ± 2.2 | 131.8 ± 2.6 | 130.9 ± 2.3 | 0.9 ± 1.4 | 0.51 |
DBP (mm Hg) | 69.2 ± 1.4 | 70.3 ± 1.5 | 71.3 ± 1.3 | -1.0 ± 1.1 | 0.34 |
LAEI (ml/mm Hg × 100) | 16.0 ± 4.7 | 14.9 ± 4.4 | 15.4 ± 5.4 | -1.0 ± 0.8 | 0.25 |
SAEI (ml/mm Hg × 100) | 7.0 ± 0.7 | 6.3 ± 0.6 | 7.3 ± 0.8 | -1.0 ± 0.5 | 0.03 |
Plasma glucose (mmol/L) | 5.8 ± 0.1 | 5.9 ± 0.1 | 5.8 ± 0.1 | 0.04 ± 0.5 | 0.64 |
Triglycerides (mmol/L) | 1.1 ± 0.1 | 1.3 ± 0.1 | 1.2 ± 0.1 | 0.1 ± 0.3 | 0.21 |
Total cholesterol (mmol/L) | 5.1 ± 0.2 | 5.4 ± 0.2 | 5.4 ± 0.2 | -0.01 ± 0.5 | 0.86 |
HDL cholesterol (mmol/L) | 1.4 ± 0.1 | 1.4 ± 0.1 | 1.4 ± 0.1 | -0.02 ± 0.1 | 0.51 |
LDL cholesterol (mmol/L) | 3.7 ± 0.1 | 3.9 ± 0.1 | 3.9 ± 0.1 | 0.002 ± 0.4 | 0.98 |
hs-CRP (mg/L) | 6.4 ± 1.7 | 4.4 ± 0.8 | 4.9 ± 1.4 | -0.5 ± 5.1 | 0.57 |